Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Working Capital/Sales

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

LINCOLN PHARMACEUTICALS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 1.661.761.811.891.88

What is the latest Working Capital/Sales ratio of LINCOLN PHARMACEUTICALS ?

The latest Working Capital/Sales ratio of LINCOLN PHARMACEUTICALS is 1.66 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.66
Mar20241.76
Mar20231.81
Mar20221.89
Mar20211.88

How is Working Capital/Sales of LINCOLN PHARMACEUTICALS Trending?

Years Working Capital/Sales % Change
Mar2025 1.66
-5.68
Mar2024 1.76
-2.76
Mar2023 1.81
-4.23
Mar2022 1.89
0.53
Mar2021 1.88 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare Working Capital/Sales ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,275.6 Cr 3.2% 43.2% 8.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 3.5% 12.3% 5.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 2.8% 7.2% 7.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 3.8% 12.1% 42.8% Stock Analytics
CIPLA ₹108,861.0 Cr 1.2% 2.8% -9.1% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr 3% 9.1% 11.6% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

3.2%

43.2%

8.4%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses